Sugentech Inc. (KOSDAQ:253840)

South Korea · Delayed Price · Currency is KRW

3,930.00

-140.00 (-3.44%)

Nov 3, 2026, 12:35 PM KST

Market Cap	60.09B -40.2%
Revenue (ttm)	9.78B -16.0%
Net Income	-23.00B
EPS	-1,504.58
Shares Out	15.29M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	34,080
Open	4,005.00
Previous Close	4,070.00
Day's Range	3,920.00 - 4,050.00
52-Week Range	3,530.00 - 8,250.00
Beta	0.68
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About Sugentech

Sugentech Inc. develops and sells in-vitro diagnostic systems and products based on biotechnology, information technology, and nanotechnology in South Korea and internationally. The company offers lab tests, including systems and test items; and COVID-19 tests. It also provides point of care testing analyzers and test items for testing of influenza A/B, antibody test, COVID-19 and flu, SARS-CoV-2, HbA1c, beta-hcg, YSH, T3/T4, and CRP; and digital health and home tests, including mobile health, ovulation, and pregnancy products. The company was ... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2011

Employees 148

Stock Exchange KOSDAQ

Ticker Symbol 253840

Full Company Profile

Financial Performance

In 2025, Sugentech's revenue was 9.42 billion, a decrease of -6.74% compared to the previous year's 10.10 billion. Losses were -23.31 billion, 53.5% more than in 2024.

Financial Statements